Citigroup’s CARGO Therapeutics CRGX Stock Holding History

Citigroup’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22,586	Closed	-$93.1K	–	6125
2025 Q2	$93.1K	Sell	22,586 -3,760	-14%	-$16.1K	﹤0.01%	4440
2025 Q1	$107K	Sell	26,346 -15,489	-37%	-$104K	﹤0.01%	4563
2024 Q4	$603K	Buy	41,835 +16,855	+67%	+$306K	﹤0.01%	3697
2024 Q3	$461K	Buy	24,980 +12,601	+102%	+$225K	﹤0.01%	3782
2024 Q2	$203K	Sell	12,379 -30,939	-71%	-$588K	﹤0.01%	3864
2024 Q1	$967K	Sell	43,318 -79,858	-65%	-$1.9M	﹤0.01%	3051
2023 Q4	$2.85M	Buy	+123,176	New	+$2.09M	﹤0.01%	1974

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citigroup's CRGX Position: Q3 2025 in Review

Citigroup sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 22,586 shares — an estimated $93.1K sold.

Citigroup first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $2.85M in Q4 2023. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Citigroup reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Citigroup sold 22,586 CARGO Therapeutics shares in Q3 2025, an estimated $93.1K.
Citigroup first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
Citigroup's CARGO Therapeutics position peaked at $2.85M in Q4 2023.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.